| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.22B | +16.5% |
| Gross profit | ¥0.01B | — |
| Operating income | ¥-0.06B | — |
| Net income | ¥-0.06B | -1349.6% |
| Gross margin | 4.6% | Net margin -27.8% |
| Revenue Q/Q | -235.4% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.21B | 95.4% |
| R&D | ¥0.02B | 8.0% |
| SG&A | ¥0.04B | 19.7% |
| Tax & other | ¥0.00B | 0.4% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
富临精工 ・ 金石亚药 ・ 中泰股份 ・ 广生堂 ・ 清水源 ・ 鹏辉能源 ・ 美康生物 ・ 运达科技 ・ 鲍斯股份 ・ 金雷股份 ・ 双杰电气 ・ 康斯特
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies